News

AGC Biologics Completes Denmark Expansion to Double Single-Use Bioreactor Capacity

June 12, 2024

The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.

Syntegon Acquires Telstar

June 11, 2024

Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.

CDER Announces Emerging Drug Safety Technology Meeting Program

June 10, 2024

The new meeting program will create a dialogue around AI and be administered through CDER’s Emerging Drug Safety Technology Program.

Drug Shortage Reports Emphasize Continuing Problems

June 10, 2024

USP and FDA publish reports detailing drug shortage numbers and challenges through 2023.

The Need for Automated and Standardized CGT Manufacturing (BIO 2024)

June 07, 2024

Lonza’s Joe Garrity and Jerry Jiang discuss the importance of not only automating CGT manufacturing, but also standardizing across processes.

Trends and Obstacles in the CGT Field (BIO 2024)

June 07, 2024

Lonza’s Joe Garrity and Jerry Jiang discuss the latest trends and challenges in commercializing new CGTs.

Demand Remains Strong for Mammalian Cell Culture Capacity (BIO 2024)

June 06, 2024

Lars Petersen, CEO, FUJIFILM Diosynth Biotechnologies discusses the company’s strategic goals and meeting market demand for mammalian cell culture capacity.

Applying AI to Molecular Structure (BIO 2024)

June 06, 2024

Founder and CEO of Atomic AI, Raphael Townshend, explores AI’s usefulness as a tool to characterize molecular structure and advance molecule engineering.

A Look at Translational CROs and PDC Modeling (BIO 2024)

June 06, 2024

Andrew Carnegie, head of Strategic Commercial Development at Inaphaea BioLabs, discusses the establishment of translational CROs and the role of PDC models in the drug discovery process.

Continuous Manufacturing and Cost of Goods (BIO 2024)

June 05, 2024

The PharmTech Group sat down with Himanshu Gadgil, CEO of Enzene Biosciences to discuss the benefits and challenges of continuous manufacturing of biopharmaceuticals.